Doreen Chaitt

1.9k total citations
12 papers, 820 citations indexed

About

Doreen Chaitt is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Doreen Chaitt has authored 12 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Doreen Chaitt's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (3 papers). Doreen Chaitt is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (3 papers). Doreen Chaitt collaborates with scholars based in United States. Doreen Chaitt's co-authors include Judith Falloon, Richard T. Davey, Joseph A. Kovacs, Michael A. Polis, Henry Masur, Julia A. Metcalf, H. Clifford Lane, John E. Bennett, Dimitrios Zonios and Robert Walker and has published in prestigious journals such as JAMA, Blood and The Journal of Infectious Diseases.

In The Last Decade

Doreen Chaitt

12 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doreen Chaitt United States 10 451 382 382 300 122 12 820
Betsey Herpin United States 12 591 1.3× 330 0.9× 417 1.1× 224 0.7× 95 0.8× 17 931
Robin Dewar United States 4 480 1.1× 302 0.8× 338 0.9× 249 0.8× 92 0.8× 4 725
Lucy Y. Shin Canada 10 442 1.0× 171 0.4× 438 1.1× 197 0.7× 59 0.5× 11 811
Cristina Gil‐Sanz Spain 17 634 1.4× 401 1.0× 317 0.8× 523 1.7× 76 0.6× 26 1.2k
Donatella Ciuffreda Italy 13 417 0.9× 331 0.9× 345 0.9× 313 1.0× 80 0.7× 24 878
Natalia Soriano-Sarabia United States 17 760 1.7× 408 1.1× 555 1.5× 268 0.9× 93 0.8× 42 1.1k
Marijke Th. L. Roos Netherlands 12 394 0.9× 212 0.6× 477 1.2× 186 0.6× 50 0.4× 17 763
Elisa De Crignis Italy 16 712 1.6× 359 0.9× 503 1.3× 173 0.6× 307 2.5× 28 1.2k
George F. Gjerset United States 6 451 1.0× 366 1.0× 155 0.4× 151 0.5× 69 0.6× 8 653
Markham Pd United States 6 354 0.8× 237 0.6× 253 0.7× 202 0.7× 93 0.8× 9 568

Countries citing papers authored by Doreen Chaitt

Since Specialization
Citations

This map shows the geographic impact of Doreen Chaitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen Chaitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen Chaitt more than expected).

Fields of papers citing papers by Doreen Chaitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen Chaitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen Chaitt. The network helps show where Doreen Chaitt may publish in the future.

Co-authorship network of co-authors of Doreen Chaitt

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen Chaitt. A scholar is included among the top collaborators of Doreen Chaitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen Chaitt. Doreen Chaitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kopka, Stacy L., et al.. (2018). A Survey on Including Risks in the New "Key Information" Section of an Informed Consent Form.. PubMed. 32(10). 18–29. 3 indexed citations
2.
Chaitt, Doreen, et al.. (2013). Protocol Development Program: A Novel Approach to Overcoming Barriers to Clinical Research.. PubMed. 27(1). 54–61. 3 indexed citations
3.
Zonios, Dimitrios, Judith Falloon, John E. Bennett, et al.. (2008). Idiopathic CD4+ Lymphocytopenia: Natural History and Prognostic Factors.. International Journal of Infectious Diseases. 12. S7–S7. 11 indexed citations
4.
Zonios, Dimitrios, Judith Falloon, John E. Bennett, et al.. (2008). Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 112(2). 287–294. 152 indexed citations
5.
Zonios, Dimitrios, et al.. (2007). Cryptococcosis and Idiopathic CD4 Lymphocytopenia. Medicine. 86(2). 78–92. 74 indexed citations
6.
Malaspina, Angela, Susan Moir, Doreen Chaitt, et al.. (2006). Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood. 109(5). 2086–2088. 88 indexed citations
7.
Farel, Claire E., Doreen Chaitt, Barbara Hahn, et al.. (2004). Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood. 103(9). 3282–3286. 33 indexed citations
8.
Davey, Richard T., Robert L. Murphy, Francesco Graziano, et al.. (2000). Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy. JAMA. 284(2). 183–183. 138 indexed citations
9.
Davey, Richard T., Doreen Chaitt, Jeffrey M. Albert, et al.. (1999). A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 179(4). 849–858. 112 indexed citations
10.
Piscitelli, Stephen C., Alan Forrest, Susan Vogel, et al.. (1998). Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics. 64(5). 492–498. 11 indexed citations
11.
Davey, Richard T., Doreen Chaitt, Stephen C. Piscitelli, et al.. (1997). Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons. The Journal of Infectious Diseases. 175(4). 781–789. 139 indexed citations
12.
Davey, Richard T., Doreen Chaitt, G. F. Reed, et al.. (1996). Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients. Antimicrobial Agents and Chemotherapy. 40(7). 1657–1664. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Betsey Herpin Breakdown of academic impact, for papers by Robin Dewar Breakdown of academic impact, for papers by Lucy Y. Shin Breakdown of academic impact, for papers by Cristina Gil‐Sanz Breakdown of academic impact, for papers by Donatella Ciuffreda Breakdown of academic impact, for papers by Natalia Soriano-Sarabia Breakdown of academic impact, for papers by Marijke Th. L. Roos Breakdown of academic impact, for papers by Elisa De Crignis Breakdown of academic impact, for papers by George F. Gjerset Breakdown of academic impact, for papers by Markham Pd
Rankless by CCL
2026